Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Siak‐Leng Choi"'
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Natural killer cell engagers (NKCEs), a treatment that stimulates innate immunity, have lately gained attention owing to their favorable safety profile, and their efficacy. Natural killer (NK) cell activation is driven by immune synapse form
Externí odkaz:
https://doaj.org/article/e0f531b75d754bf985029b5bf7872dc6
Autor:
Thomas M. Tzschentke, Estelle Watson, Feras Khalil, Claudia Lefeber, Jan Freijer, Mariëlle Eerdekens, Siak Leng Choi
Publikováno v:
Journal of Pain Research. 13:3107-3123
Objective The main aim of this analysis was to characterize the pharmacokinetics (PK) of tapentadol in pediatric patients from birth to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe1ea0e5875f96a9704d3c7b58c95c20
https://doi.org/10.2147/jpr.s269549
https://doi.org/10.2147/jpr.s269549
Autor:
Feras, Khalil, Siak Leng, Choi, Estelle, Watson, Thomas M, Tzschentke, Claudia, Lefeber, Mariëlle, Eerdekens, Jan, Freijer
Publikováno v:
Journal of Pain Research
Objective The main aim of this analysis was to characterize the pharmacokinetics (PK) of tapentadol in pediatric patients from birth to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ae308755073f514333356bfed82cefa
https://pubmed.ncbi.nlm.nih.gov/33262645
https://pubmed.ncbi.nlm.nih.gov/33262645
Autor:
Subhashis Banerjee, Gregory S Cameron, Julie Satterwhite, Siak‐Leng Choi, Lai‐San Tham, Cheng‐Cai Tang
Publikováno v:
The Journal of Clinical Pharmacology. 54:1117-1124
Ixekizumab (LY2439821), a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody that selectively binds and neutralizes interleukin (IL) 17A has demonstrated efficacy in the treatment of psoriasis. A population pharmacokinetics-pharmacodyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6846bbaf1c4d84b4fe726adf7228b5ab
https://doi.org/10.1002/jcph.312
https://doi.org/10.1002/jcph.312
Autor:
Lai-San, Tham, Cheng-Cai, Tang, Siak-Leng, Choi, Julie H, Satterwhite, Gregory S, Cameron, Subhashis, Banerjee
Publikováno v:
Journal of clinical pharmacology. 54(10)
Ixekizumab (LY2439821), a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody that selectively binds and neutralizes interleukin (IL) 17A has demonstrated efficacy in the treatment of psoriasis. A population pharmacokinetics-pharmacodyna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7fde76fa37a5f86d002ab508654b5cb1
https://pubmed.ncbi.nlm.nih.gov/24752880
https://pubmed.ncbi.nlm.nih.gov/24752880
Autor:
Vikram P, Sinha, Siak Leng, Choi, Danny Kwang Wei, Soon, Kenneth F, Mace, Kwee Poo, Yeo, Shufen T H, Lim, Daniel C, Howey
Publikováno v:
Journal of clinical pharmacology. 54(7)
LY2605541 is a novel basal insulin analog with a prolonged duration of action. Two Phase I studies assessed LY2605541 pharmacokinetics (PK), glucodynamics (GD), and tolerability in healthy subjects. In Study 1, 33 subjects received single subcutaneou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d504037327abbbc372a6697e212b24c5
https://pubmed.ncbi.nlm.nih.gov/24504686
https://pubmed.ncbi.nlm.nih.gov/24504686
Autor:
Henry, Robert R., Mudaliar, Sunder, Ciaraldi, Theodore P., Armstrong, Debra A., Burke, Paivi, Pettus, Jeremy, Garhyan, Parag, Siak Leng Choi, Jacober, Scott J., Knadler, Mary Pat, Lam, Eric Chen Quin, Prince, Melvin J., Bose, Namrata, Porksen, Niels, Sinha, Vikram P., Linnebjerg, Helle
Publikováno v:
Diabetes Care; Sep2014, Vol. 37 Issue 9, p2609-2615, 7p, 1 Chart, 3 Graphs
Autor:
Sinha, Vikram P., Siak Leng Choi, Kwang Wei Soon, Danny, Mace, Kenneth F., Kwee Poo Yeo, H. Lim, Shufen T., Howey, Daniel C.
Publikováno v:
Journal of Clinical Pharmacology; Feb2014, Vol. 54 Issue 2, p1-8, 8p, 2 Charts, 3 Graphs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.